SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing intense selling pressure as investors express concerns over rising AI-related capital expenditures and a credit rating downgrade, leading the stock to test fresh 52-week lows. While some in the community see the sharp decline as a deep-value buying opportunity fueled by long-term cloud and AI infrastructure growth, others remain skeptical, citing high debt levels and aggressive short-selling activity.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is facing intense volatility as traders grapple with significant margin calls among leveraged retail accounts in South Korea, alongside concerns regarding central bank rebalancing and broader economic uncertainty. Community discussion is sharply divided between those viewing the rapid decline as a deep-value buying opportunity ahead of a pending stock split and those warning of the risks inherent in holding a 3x leveraged ETF during a high-volatility drawdown.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy is drawing intense investor attention as community members analyze its critical role in the AI data center power infrastructure, specifically highlighting partnerships with Nvidia and Siemens. While some traders are expressing frustration over intraday volatility and selling pressure from institutional holders, bullish sentiment remains centered on the company's massive order backlog and its potential as an essential utility-scale storage provider.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is currently trending as investors debate its long-term potential against a backdrop of sector-wide volatility and disappointing recent price action. While some market participants are aggressively buying the dip, citing strong government contracts and institutional partnerships as catalysts for a future rebound, others are wary of the company's high cash burn and the broader sell-off affecting the entire quantum sector.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending as investors react to the company's extreme volatility and speculation surrounding Donald Trump's ongoing policy announcements, including recent declarations about the Strait of Hormuz. Community discussion is polarized, with intense debate over the stock's fundamental value and the broader geopolitical implications of current administration actions.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin shares experienced intense volatility and a sharp intraday reversal, as traders reacted to a mix of positive sentiment around AI-driven ad-tech monetization and a sudden mid-session sell-off that wiped out early gains. Investors remain focused on the potential impact of the AXON platform rollout and the broader rotation of capital back into high-growth software names.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is trending as investors debate the impact of newly raised Q2 revenue guidance and the official launch of Gorilla Tech Capital, which aims to secure non-dilutive institutional funding for major AI infrastructure projects. The community remains sharply divided, with bulls pointing to the company's expanding backlog and potential short-squeeze dynamics, while vocal skeptics continue to raise concerns regarding institutional ownership, past management credibility, and broader market headwinds.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is currently facing intense selling pressure as investors grapple with significant share dilution from recent acquisitions and concerns over the company's long-term profitability. While the community remains deeply divided between long-term bulls highlighting the potential of the autonomous drone and defense sector and vocal bears focused on technical weakness, many are closely watching key support levels and upcoming earnings for a potential trend reversal.

Factorial Energy, Inc. engages in the development and commercialization of solid-state battery technologies. Its platforms include FEST and Solstice, designed to deliver high-performance, scalable battery solutions for applications in drones, robotics, automotive, and other advanced mobility sectors. The company is headquartered in Billerica, MA.

Factorial Energy Inc. - Ordinary Shares- Class A

Factorial Energy Inc

Factorial Energy is experiencing high volatility as investors react to a strategic partnership with Tulip Tech aimed at advancing solid-state battery technology for the aerospace and drone sectors. The community remains deeply divided, with some traders actively looking to buy the dip as a long-term play on battery innovation, while others express concerns over potential dilution and the company's long-term commercial viability.

Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.

Q32 Bio Inc.

Q32 Bio is trending following a positive clinical trial readout for its alopecia treatment, which has ignited significant investor interest despite ongoing discussions regarding a major public offering. Community sentiment remains split, with bulls focused on the company's potential upside and momentum, while bears highlight concerns over potential share dilution and the stock's recent volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pulmonx Corporation (NASDAQ:LUNG) Receives Consensus Recommendation of "Hold" from Analysts

Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) has received an average rating of "Hold" from the eight research firms that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold reco...

Pulmonx (NASDAQ:LUNG) Downgraded to "Sell" Rating by Wall Street Zen

Wall Street Zen lowered Pulmonx from a "hold" rating to a "sell" rating in a research report on Saturday...

Pulmonx's (LUNG) Buy Rating Reiterated at D. Boral Capital

D. Boral Capital reiterated a "buy" rating and issued a $14.00 price target on shares of Pulmonx in a report on Thursday...

Pulmonx Q1 Earnings Call Highlights

Pulmonx (NASDAQ:LUNG) reported first-quarter 2026 worldwide revenue of $20.6 million, as management emphasized early progress on commercial execution, continued advancement of its AeriSeal clinical program, and actions to reduce spending and extend its cash runway. Executives reiterated full-year 20...

Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates

Pulmonx (LUNG) delivered earnings and revenue surprises of 0.00% and +2.52%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Pulmonx (NASDAQ:LUNG) Releases Quarterly Earnings Results, Meets Expectations

Pulmonx (NASDAQ:LUNG - Get Free Report) released its earnings results on Wednesday. The company reported ($0.33) EPS for the quarter, hitting analysts' consensus estimates of ($0.33). Pulmonx had a...

Pulmonx (LUNG) Projected to Post Earnings on Wednesday

Pulmonx (NASDAQ:LUNG) will be releasing its Q1 2026 earnings after the market closes on Wednesday, April 29. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-29-pulmonx-co-stock...

Pulmonx Corporation (NASDAQ:LUNG) Short Interest Update

Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) saw a significant drop in short interest in the month of March. As of March 31st, there was short interest totaling 2,857,097 shares, a drop of...

Hims & Hers Health (HIMS) Soars 11.1%: Is Further Upside Left in the Stock?

Hims & Hers Health (HIMS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Pulmonx (NASDAQ:LUNG) Stock Price Up 2.3%  - Still a Buy?

Pulmonx (NASDAQ:LUNG) Shares Up 2.3% - Time to Buy...

Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the United States, Europe, Middle East, Africa, Asia Pacific, and Other International segments. The company was founded by Rodney Perkins on December 26, 1995 and is headquartered in Redwood City, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.28	--	--	N/A
Q1 '26	-$0.33	-$0.33	-1.02%	MISSED
Q4 '25	-$0.38	-$0.25	35.06%	BEAT
Q3 '25	-$0.42	-$0.34	19.43%	BEAT
Q2 '25	-$0.40	-$0.38	5.39%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

LUNGPulmonx Corp

Upcoming Earnings: Q2 '26

Historical Earnings

Latest LUNG News